Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Petria S. Thompson"'
Autor:
Ulysses G. Gardner, Petria S. Thompson, Jason Burton, Caleb Stewart, C. David Fuller, Michael K. Rooney, Ethan B. Ludmir
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1413-1417 (2021)
Externí odkaz:
https://doaj.org/article/fd1d8f2cd4104f72b81e29ede5619ec9
Autor:
Sheetal Uppal, Anne Gegonne, Qingrong Chen, Petria S. Thompson, Dan Cheng, Jie Mu, Daoud Meerzaman, Hari S. Misra, Dinah S. Singer
Publikováno v:
Cell Reports, Vol 29, Iss 8, Pp 2450-2460.e5 (2019)
Summary: The bromodomain protein 4 (BRD4) is an atypical kinase and histone acetyl transferase (HAT) that binds to acetylated histones and contributes to chromatin remodeling and early transcriptional elongation. During transcription, BRD4 travels wi
Externí odkaz:
https://doaj.org/article/a0a7baa9ece248b081b81f1d1e967938
Autor:
Ramez Kouzy, Maddie C. Turner, Marc Ghabach, Cullen M. Taniguchi, Bruce D. Minsky, Ethan B. Ludmir, Michael K. Rooney, Petria S. Thompson, Joseph Abi Jaoude, C. David Fuller, Roshal R. Patel
Publikováno v:
Oncotarget
Purpose: Journal impact factor (IF) is often used to measure research quality and importance. We assessed trial factors associated with the publication of cancer trials in journals with higher IF and publications receiving higher citations. Materials
Autor:
C. David Fuller, Caleb Stewart, Ulysses Gardner, Petria S. Thompson, Ethan B. Ludmir, Michael K. Rooney, Jason C. Burton
Publikováno v:
JCO Global Oncology
Autor:
Kareem N Mohni, Petria S Thompson, Jessica W Luzwick, Gloria G Glick, Christopher S Pendleton, Brian D Lehmann, Jennifer A Pietenpol, David Cortez
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0125482 (2015)
The DNA damage response kinase ATR may be a useful cancer therapeutic target. ATR inhibition synergizes with loss of ERCC1, ATM, XRCC1 and DNA damaging chemotherapy agents. Clinical trials have begun using ATR inhibitors in combination with cisplatin
Externí odkaz:
https://doaj.org/article/f9c69894fe6f41d8ba3ba6c828bd46d4
Publikováno v:
Nature structural & molecular biology
Abasic (AP) sites are one of the most common DNA lesions that block replicative polymerases. 5-hydroxymethylcytosine binding, embryonic stem cell-specific protein (HMCES) recognizes and processes these lesions in the context of single-stranded DNA (s
Autor:
Qing-Rong Chen, Sheetal Uppal, Hari S. Misra, Dinah S. Singer, Anne Gegonne, Petria S. Thompson, Jie Mu, Daoud Meerzaman, Dan Cheng
Publikováno v:
Cell Reports, Vol 29, Iss 8, Pp 2450-2460.e5 (2019)
Summary: The bromodomain protein 4 (BRD4) is an atypical kinase and histone acetyl transferase (HAT) that binds to acetylated histones and contributes to chromatin remodeling and early transcriptional elongation. During transcription, BRD4 travels wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61751a7939ddf1c7ff72b794deb65f44
https://europepmc.org/articles/PMC6893865/
https://europepmc.org/articles/PMC6893865/
Autor:
Petria S. Thompson, Ethan B. Ludmir, Ulysses Gardner, C.D. Fuller, Michael K. Rooney, Caleb Stewart, Jason C. Burton, Alex Koong
Publikováno v:
Journal of Clinical Oncology. 39:11032-11032
11032 Background: The open access (OA) publishing model represents an exciting opportunity to facilitate dissemination of scientific information to global audiences. In contrast to many traditional models, which require readers to pay subscription fe
Autor:
Kristen R. Scarpato, Petria S. Thompson, Matthew J. Resnick, David F. Penson, Elizabeth Green, Daniel A. Barocas, Sam S. Chang, Kirk A. Keegan
Publikováno v:
Journal of Urology. 201
Autor:
Elizabeth Green, Daniel A. Barocas, Sam S. Chang, Kristen R. Scarpato, Petria S. Thompson, Matthew J. Resnick, David F. Penson, Kirk A. Keegan
Publikováno v:
Journal of Urology. 201